Icade SA
Icade SA Fundamental Analysis
Icade SA (CDMGF) shows weak financial fundamentals with a PE ratio of -13.33, profit margin of -9.25%, and ROE of -3.16%. The company generates $1.3B in annual revenue with weak year-over-year growth of -4.98%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 2.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CDMGF's fundamental strength across five key dimensions:
Efficiency Score
WeakCDMGF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentCDMGF trades at attractive valuation levels.
Growth Score
ModerateCDMGF shows steady but slowing expansion.
Financial Health Score
ModerateCDMGF shows balanced financial health with some risks.
Profitability Score
WeakCDMGF struggles to sustain strong margins.
Key Financial Metrics
Is CDMGF Expensive or Cheap?
P/E Ratio
CDMGF trades at -13.33 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, CDMGF's PEG of -0.45 indicates potential undervaluation.
Price to Book
The market values Icade SA at 0.42 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 188.10 times EBITDA. This signals the market has high growth expectations.
How Well Does CDMGF Make Money?
Net Profit Margin
For every $100 in sales, Icade SA keeps $-9.25 as profit after all expenses.
Operating Margin
Core operations generate 20.77 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-3.16 in profit for every $100 of shareholder equity.
ROA
Icade SA generates $-1.29 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Icade SA produces operating cash flow of $314.73M, showing steady but balanced cash generation.
Free Cash Flow
Icade SA produces free cash flow of $129.92M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $1.71 in free cash annually.
FCF Yield
CDMGF converts 7.94% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-13.33
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.45
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.42
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.23
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.13
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.33
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.03
vs 25 benchmark
ROA
Return on assets percentage
-0.01
vs 25 benchmark
ROCE
Return on capital employed
0.03
vs 25 benchmark
How CDMGF Stacks Against Its Sector Peers
| Metric | CDMGF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -13.33 | 22.46 | Better (Cheaper) |
| ROE | -3.16% | 681.00% | Weak |
| Net Margin | -9.25% | -37308.00% (disorted) | Weak |
| Debt/Equity | 1.13 | -20.87 (disorted) | Distorted |
| Current Ratio | 1.33 | 1953.63 | Neutral |
| ROA | -1.29% | -1226.00% (disorted) | Weak |
CDMGF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Icade SA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-7.26%
Industry Style: Income, Inflation Hedge, REIT
DecliningEPS CAGR
-189.68%
Industry Style: Income, Inflation Hedge, REIT
DecliningFCF CAGR
-3.11%
Industry Style: Income, Inflation Hedge, REIT
Declining